secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2026-03-09T23:59:59+00:00
Accession:  0001193125-26-098493
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Larimar Therapeutics posts updated corporate presentation; no material news disclosed
--------------------------------------------------------------------------------

- Company made updated corporate slide presentation available on its website on March 9, 2026.
- Presentation will be used in meetings with investors and analysts.
- No specific financial results, guidance, or material events were disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000119312526098493/0001193125-26-098493-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000119312526098493/lrmr-20260309.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-098493

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer